-

AIS Healthcare Celebrates Brain Injury Awareness Month

DALLAS--(BUSINESS WIRE)--AIS Healthcare is proud to recognize March as Brain Injury Awareness month and celebrates the advances in both care and awareness that have benefitted the brain injury community. AIS Healthcare is committed to improving care in addition to raising awareness for issues that affect the 5.3 million individuals in the United States living with a brain injury or brain injury-related disability.

“Individuals who have acquired a brain injury deserve access to the care and support that enables them to thrive in their careers and lead fulfilling lives,” said Simon Castellanos, AIS Healthcare Chief Executive Officer. “At AIS Healthcare, we take pride in our work to offer best-in-class medication and services to support this community.”

The Centers for Disease Control and Prevention (CDC) estimates an average of 1.5 million traumatic brain injuries (TBI) occur each year, however misunderstandings about TBI and its potential impacts are commonplace. This is why Brain Injury Awareness Month is so important for illustrating the need for better understanding and advocacy.

To reduce the occurrence of brain injury, it is recommended to always wear a seatbelt, helmets, and never drive impaired. Reducing the risk of injury lowers the number of people who will need treatment or hospitalization after an injury occurs. For more information about prevention strategies and how to support the brain injury community, contact your local brain injury association by visiting here.

About AIS Healthcare

Advancing quality. Improving lives.

As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.

Learn more at aiscaregroup.com

Contacts

Simon Castellanos
877.443.4006

Industry:

AIS Healthcare

Release Versions
English

Contacts

Simon Castellanos
877.443.4006

More News From AIS Healthcare

Advanced Infusion Care (AIC) now offers GC Biopharma’s ALYGLO™ [Immune Globulin Intravenous (Human-stwk) 10% liquid]

DALLAS--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers ALYGLO™, manufactured by GC Biopharma, for the treatment of patients with primary humoral immunodeficiency (PI) in adults. This includes, but is not limited to, the humoral immune defect in congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiency (SCID). The nationally accredited home infusion teams at AIC collaborate c...

AIS Healthcare Supports Physicians and Patients Impacted by Hurricanes Helene and Milton

DALLAS--(BUSINESS WIRE)--In response to recent hurricanes that devastated many communities across the Southeastern United States, AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is providing additional support to physicians and patients to ensure continuity of care and access to life-saving medication. The destruction of critical infrastructure and extended power outages have created acute challenges for patients who rely on timely delivery and su...

Advanced Infusion Care (AIC) Announces New Hire to Trade & Procurement Team

DALLAS--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, today announced the hiring of Stan Singley as Vice President of Trade and Procurement. In this role, Stan will help drive AIC’s growth and expansion strategy in partnering with pharmaceutical manufacturers to gain limited distribution and sole source access for specialty drugs. “We are thrilled to welcome a highly respected industry veteran with more than 20+ years of experience in immunology and rare diseases,” said Jud Hall, Presiden...
Back to Newsroom